Legislative Research: WI AB1134 | 2021-2022 | Regular Session

Other Sessions

SessionTitle/DescriptionLast Action
2023-2024
Regular Session

(Failed)
An Act to create 146.901 of the statutes; Relating to: prescription drug cost reporting by manufacturers and providing a penalty.
[AB1134 2023 Detail][AB1134 2023 Text][AB1134 2023 Comments]
2024-04-15
Failed to pass pursuant to Senate Joint Resolution 1
2021-2022
Regular Session

(Failed)
An Act to repeal 27.01 (8) (bn), 27.01 (8) (c) 2. and 3., 27.01 (8m) (a) 1., 27.01 (8m) (b) and 27.01 (9) (c); to renumber 27.01 (8) (c) 1.; to consolidate, renumber and amend 27.01 (8m) (a) (intro.) and 2.; to amend 27.01 (8) (a), 27.01 (8) (b) (int...
[AB1134 2021 Detail][AB1134 2021 Text][AB1134 2021 Comments]
2022-04-27
Fiscal estimate received

References Online

Search PhraseWebNewsFinancialEncylopediaBiography
[Wisconsin AB1134]Google WebGoogle News
[Representative Gary Hebl WI]Google WebGoogle NewsFollowTheMoneyBallotpediaVoteSmart

Legislative Citation

APA
WI AB1134 | 2021-2022 | Regular Session. (2022, April 27). LegiScan. Retrieved November 17, 2024, from https://legiscan.com/WI/bill/AB1134/2021
MLA
"WI AB1134 | 2021-2022 | Regular Session." LegiScan. LegiScan LLC, 27 Apr. 2022. Web. 17 Nov. 2024. <https://legiscan.com/WI/bill/AB1134/2021>.
Chicago
"WI AB1134 | 2021-2022 | Regular Session." April 27, 2022 LegiScan. Accessed November 17, 2024. https://legiscan.com/WI/bill/AB1134/2021.
Turabian
LegiScan. WI AB1134 | 2021-2022 | Regular Session. 27 April 2022. https://legiscan.com/WI/bill/AB1134/2021 (accessed November 17, 2024).

Wisconsin State Sources


feedback